Company / Net Income
Viking Therapeutics, Inc. Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$359.6M
FY2025
5-year range
-$359.6M / -$39.5M
FY2021-FY2025
Trend
-227.1%
vs FY2024
Sector context
#188 of 216
Health Care
What the data says
Net Income changed -227% YoY in FY2025, a notable deviation from the 9-year average annual change of -48%.
Based on SEC 10-K filings.
-$360M in FY2025.
Declined from -$55M to -$360M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 13% in Health CareTop 87% of 216This company -$359.6M Sector average $454.3M
▼
-179.2% below sector average
Key checks
Key Insights
- In FY2025, net income decreased 227.1% year-over-year.
- Ranks #188 out of 216 companies in the Health Care sector.
- Peak net income was recorded in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$359.6M | -227.1% |
| FY2024 | -$110.0M | -100.0% |
| FY2023 | -$55.0M | +0.0% |
| FY2022 | -$55.0M | -39.2% |
| FY2021 | -$39.5M | -53.2% |
| FY2020 | -$25.8M | -16.8% |
| FY2019 | -$22.1M | -7.2% |
| FY2018 | -$20.6M | +0.0% |
| FY2017 | -$20.6M | +12.1% |
| FY2016 | -$23.4M | -6.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026